Geraldo Renato de Paula
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Geraldo Renato de Paula has a total of 53 co-authors. Here are the top co-authors by number of shared publications:
- Felipe Lopes Teixeira
The University of Kansas
4 shared publications - Lenise Arneiro Teixeira
Universidade Federal Fluminense
4 shared publications - Rosana Rocha Barros
Instituto Biomédico, Universidade Federal Fluminense Niterói Rio de Janeiro Brazil
3 shared publications - Bruna Maiara Ferreira Barreto Pires
Universidade Federal Fluminense, Brasil
2 shared publications - Heidi Pauer
University of Kansas
2 shared publications - Keila de Cássia Ferreira de Almeida Silva
Universidade Federal Fluminense
2 shared publications
Latest Publications
- Open Access
- 30 July 2026
- Published by Wiley in Tropical Medicine & International Health
- Vol. 31 (11) , 1701-1707
Vaccine Targets and Antimicrobial Resistance of Streptococcus agalactiae Recovered From Pregnant Women in Brazil
Objectives: The available measure to prevent Streptococcus agalactiae (Group B Streptococcus, GBS ) neonatal infection is intrapartum antibiotic prophylaxis ( IAP ), but it is threatened by bacterial resistance. Therefore, this study aimed to investigate antimicrobial resistance and bacterial targets of vaccines at the most advanced stage of development. Methods: GBS isolates ( n = 222) recovered from pregnant women between 2019 and 2024 were subjected to capsular polysaccharides and alpha‐like proteins investigation and antimicrobial susceptibility testing. Macrolide and fluoroquinolone resistance determinants and genetic diversity of multidrug‐resistant ( MDR ) isolates were also investigated. Results: The main capsular types were Ia (78, 35.1%), III (42, 18.9%), V (39, 17.6%) and II (32, 14.4%). Vaccines based on hexavalent capsular polysaccharides and alpha‐like proteins would have 97.3% and 87.5% of predicted efficacy, respectively. Isolates were categorized as not susceptible ( NS ), that is, intermediate and resistant, to levofloxacin (5, 2.3%), clindamycin (11, 5%), erythromycin (58, 26.1%) and tetracycline (171, 77%). Among erythromycin NS isolates, the M phenotype/ mef (A ) gene predominated (47, 81%). All levofloxacin‐resistant isolates showed amino acid substitutions in both GyrA ( S81L ) and ParC ( S79F ). MDR isolates (10, 4.5%) had distinct genetic backgrounds. Conclusions: Both immunization approaches would be effective in the population. Although the elevated erythromycin resistance rate, one of the highest reported in the country, clindamycin remains an efficient option in IAP. MDR isolates have not resulted from the dissemination of a single clone, but instead showed a polyclonal origin.
- 30 July 2026
- Published by Wiley in Tropical Medicine & International Health
- Vol. 31 (11) , 1701-1707
Open AccessVaccine Targets and Antimicrobial Resistance of Streptococcus agalactiae Recovered From Pregnant Women in Brazil
Objectives: The available measure to prevent Streptococcus agalactiae (Group B Streptococcus, GBS ) neonatal infection is intrapartum antibiotic prophylaxis ( IAP ), but it is threatened by bacterial resistance. Therefore, this study aimed to investigate antimicrobial resistance and bacterial targets of vaccines at the most advanced stage of development. Methods: GBS isolates ( n = 222) recovered from pregnant women between 2019 and 2024 were subjected to capsular polysaccharides and alpha‐like proteins investigation and antimicrobial susceptibility testing. Macrolide and fluoroquinolone resistance determinants and genetic diversity of multidrug‐resistant ( MDR ) isolates were also investigated. Results: The main capsular types were Ia (78, 35.1%), III (42, 18.9%), V (39, 17.6%) and II (32, 14.4%). Vaccines based on hexavalent capsular polysaccharides and alpha‐like proteins would have 97.3% and 87.5% of predicted efficacy, respectively. Isolates were categorized as not susceptible ( NS ), that is, intermediate and resistant, to levofloxacin (5, 2.3%), clindamycin (11, 5%), erythromycin (58, 26.1%) and tetracycline (171, 77%). Among erythromycin NS isolates, the M phenotype/ mef (A ) gene predominated (47, 81%). All levofloxacin‐resistant isolates showed amino acid substitutions in both GyrA ( S81L ) and ParC ( S79F ). MDR isolates (10, 4.5%) had distinct genetic backgrounds. Conclusions: Both immunization approaches would be effective in the population. Although the elevated erythromycin resistance rate, one of the highest reported in the country, clindamycin remains an efficient option in IAP. MDR isolates have not resulted from the dissemination of a single clone, but instead showed a polyclonal origin.
- 24 May 2026
- Published by Taylor & Francis in Future Microbiology
- Vol. 21 (8) , 713-723
Antibiofilm activity of cell-free supernatants from bacteria isolated from chronic wounds against Staphylococcus aureus
1. Bacterial biofilms, related to the formation of a self-produced extracellular matrix [1,2], are frequently observed in chronic wounds and contribute with pathogenic microorganisms to be installe...
- 24 May 2026
- Published by Taylor & Francis in Future Microbiology
- Vol. 21 (8) , 713-723
Antibiofilm activity of cell-free supernatants from bacteria isolated from chronic wounds against Staphylococcus aureus
1. Bacterial biofilms, related to the formation of a self-produced extracellular matrix [1,2], are frequently observed in chronic wounds and contribute with pathogenic microorganisms to be installe...
- Open Access
- 27 November 2024
- Published by Editora e Distribuidora Educacional in Ensaios e Ciência: C. Biológicas, Agrárias e da Saúde
- Vol. 28 (4) , 532-535
Mastitis-Associated Bacterial Etiologies and Antimicrobial Susceptibility Profiles
Cattle mastitis is common in dairy farms, affecting animal welfare and the profitability of production. Mastitis contributes to antimicrobial agent consumption in animal and agriculture sectors, which might impact the occurrence and dissemination of multidrug-resistant microorganisms. To overcome this scenario, it is important to identify the etiology and treat it correctly, which does not occur in the majority of farms in Brazil. This study identified the etiology, by MALDI-TOF MS, and analyzed the antimicrobial susceptibility profile of bacterial isolates recovered from milk samples of 122 animals, with clinical or subclinical mastitis. Sampling occurred during June and July 2021, in farms located in the cities of Lima Duarte, Pedro Teixeira, and Bias Fortes, mesoregion Zona da Mata of Minas Gerais, the major milk producer state of Brazil. The prevalent species was Staphylococcus aureus (27.7%), followed by Streptococcus uberis (13.1%) and Streptococcus agalactiae (8%). Staphylococcus and Streptococcus species showed resistance to several antimicrobials, however, they were susceptible to the recommended veterinary drugs ceftiofur and penicillin-novobiocin. Escherichia coli was recovered in 3.6% and showed resistance to ceftiofur and other drugs. Multidrug resistance has varied from 2.6% in S. aureus to 60% in E. coli isolates. Results show that all classical mastitis pathogens continue to cause infection in this region, despite improved control programs. The spread of bacterial isolates resistant to veterinary and human antimicrobials, besides contributing to treatment failure, represents a major concern under the view of the one health approach. Keywords: Cattle Mastitis. Bacterial Pathogens. MALDI-TOF MS. Antimicrobial Resistance. Resumo A mastite bovina é comum nas fazendas leiteiras, afetando o bem-estar animal e a lucratividade da produção. A mastite contribui para o consumo de antimicrobianos nos setores animal e agrícola, o que pode impactar na ocorrência e disseminação de microrganismos multirresistentes. Para superar esse cenário, é importante identificar a etiologia e tratá-la corretamente, o que não ocorre na maioria das fazendas do Brasil. Este estudo identificou a etiologia, por MALDI-TOF MS, e analisou o perfil de suscetibilidade antimicrobiana de bactérias isoladas de amostras de leite de 122 animais, com mastite clínica ou subclínica. As coletas ocorreram entre junho e julho de 2021, em fazendas localizadas nos municípios de Lima Duarte, Pedro Teixeira e Bias Fortes, mesorregião Zona da Mata de Minas Gerais, o maior estado produtor de leite do Brasil. A espécie prevalente foi Staphylococcus aureus (27,7%), seguida de Streptococcus uberis (13,1%) e Streptococcus agalactiae (8%). Espécies de Staphylococcus e Streptococcus mostraram resistência a vários antimicrobianos, entretanto, foram suscetíveis a ceftiofur e penicilina-novobiocina, drogas recomendadas na veterinária. Escherichia coli foi isolada em 3,6% e apresentou resistência ao ceftiofur e outras drogas. A resistência a múltiplas drogas variou de 2,6% em S. aureus a 60% em E. coli. Os resultados mostram que todos os patógenos clássicos da mastite continuam a causar infecção nessa região, apesar dos programas de controle aprimorados. A disseminação de amostras bacterianas resistentes a antimicrobianos veterinários e humanos, além de contribuir para falhas de tratamento, representa uma grande preocupação sob a ótica da abordagem de saúde única. Palavras-chave: Mastite Bovina. Patógenos Bacterianos. MALDI-TOF MS. Resistência antimicrobiana.
- 27 November 2024
- Published by Editora e Distribuidora Educacional in Ensaios e Ciência: C. Biológicas, Agrárias e da Saúde
- Vol. 28 (4) , 532-535
Open AccessMastitis-Associated Bacterial Etiologies and Antimicrobial Susceptibility Profiles
Cattle mastitis is common in dairy farms, affecting animal welfare and the profitability of production. Mastitis contributes to antimicrobial agent consumption in animal and agriculture sectors, which might impact the occurrence and dissemination of multidrug-resistant microorganisms. To overcome this scenario, it is important to identify the etiology and treat it correctly, which does not occur in the majority of farms in Brazil. This study identified the etiology, by MALDI-TOF MS, and analyzed the antimicrobial susceptibility profile of bacterial isolates recovered from milk samples of 122 animals, with clinical or subclinical mastitis. Sampling occurred during June and July 2021, in farms located in the cities of Lima Duarte, Pedro Teixeira, and Bias Fortes, mesoregion Zona da Mata of Minas Gerais, the major milk producer state of Brazil. The prevalent species was Staphylococcus aureus (27.7%), followed by Streptococcus uberis (13.1%) and Streptococcus agalactiae (8%). Staphylococcus and Streptococcus species showed resistance to several antimicrobials, however, they were susceptible to the recommended veterinary drugs ceftiofur and penicillin-novobiocin. Escherichia coli was recovered in 3.6% and showed resistance to ceftiofur and other drugs. Multidrug resistance has varied from 2.6% in S. aureus to 60% in E. coli isolates. Results show that all classical mastitis pathogens continue to cause infection in this region, despite improved control programs. The spread of bacterial isolates resistant to veterinary and human antimicrobials, besides contributing to treatment failure, represents a major concern under the view of the one health approach. Keywords: Cattle Mastitis. Bacterial Pathogens. MALDI-TOF MS. Antimicrobial Resistance. Resumo A mastite bovina é comum nas fazendas leiteiras, afetando o bem-estar animal e a lucratividade da produção. A mastite contribui para o consumo de antimicrobianos nos setores animal e agrícola, o que pode impactar na ocorrência e disseminação de microrganismos multirresistentes. Para superar esse cenário, é importante identificar a etiologia e tratá-la corretamente, o que não ocorre na maioria das fazendas do Brasil. Este estudo identificou a etiologia, por MALDI-TOF MS, e analisou o perfil de suscetibilidade antimicrobiana de bactérias isoladas de amostras de leite de 122 animais, com mastite clínica ou subclínica. As coletas ocorreram entre junho e julho de 2021, em fazendas localizadas nos municípios de Lima Duarte, Pedro Teixeira e Bias Fortes, mesorregião Zona da Mata de Minas Gerais, o maior estado produtor de leite do Brasil. A espécie prevalente foi Staphylococcus aureus (27,7%), seguida de Streptococcus uberis (13,1%) e Streptococcus agalactiae (8%). Espécies de Staphylococcus e Streptococcus mostraram resistência a vários antimicrobianos, entretanto, foram suscetíveis a ceftiofur e penicilina-novobiocina, drogas recomendadas na veterinária. Escherichia coli foi isolada em 3,6% e apresentou resistência ao ceftiofur e outras drogas. A resistência a múltiplas drogas variou de 2,6% em S. aureus a 60% em E. coli. Os resultados mostram que todos os patógenos clássicos da mastite continuam a causar infecção nessa região, apesar dos programas de controle aprimorados. A disseminação de amostras bacterianas resistentes a antimicrobianos veterinários e humanos, além de contribuir para falhas de tratamento, representa uma grande preocupação sob a ótica da abordagem de saúde única. Palavras-chave: Mastite Bovina. Patógenos Bacterianos. MALDI-TOF MS. Resistência antimicrobiana.
- Open Access
- 6 July 2024
- Published by Elsevier in Regenerative Therapy
- Vol. 26, 425-431
Wound fluid sampling methods and analysis of cytokine mRNA expression in ulcers from patients with diabetes mellitus
- 6 July 2024
- Published by Elsevier in Regenerative Therapy
- Vol. 26, 425-431
Open AccessWound fluid sampling methods and analysis of cytokine mRNA expression in ulcers from patients with diabetes mellitus
- Open Access
- 21 February 2024
- Published by Editora Unijui in Revista Contexto & Saúde
- Vol. 24 (48) , e14385
Uso de antimicrobianos em hospital especializado em cardiologia
The management of antimicrobial use has been recognized as a relevant action to mitigate irrational use and the increasing resistance to this class of drugs. Thus, the present study aimed to evaluate the use of antimicrobials by measuring consumption and assessing the appropriateness of treatment regarding indication, dose, and duration, from August to November 2019, in a cardiology specialized hospital. Empirically initiated treatments were also evaluated for their adequacy following culture results and antimicrobial sensitivity testing, with adjustments made as necessary. Additionally, the World Health Organization (WHO) classification was applied, categorizing antimicrobials into Access, Watch, and Reserve (AWaRe) groups based on the impact of their use on microbial resistance and the importance of their appropriate and restricted use. A total of 1558 prescriptions associated with 405 treatments were evaluated. The most commonly used therapeutic classes were combined penicillins, carbapenems, and third-generation cephalosporins. Adequacy in indication was observed in 84.2% of cases. Among these, 88.1% and 90.6% exhibited appropriate dose and treatment duration, respectively. Empirically initiated treatments were predominantly conducted (58.7%) with antimicrobials from the Watch group, followed by the Reserve group (23.5%) and Access group (17.8%). Therapy adjustment was performed in 59% of cases requiring it (57.9%). The results suggest that antimicrobial use should be optimized, aiming to minimize empirical use, favor the use of antimicrobials from the Access category, and promote the adequacy of empirical treatments following culture results. O gerenciamento do uso de antimicrobianos tem sido apontado como ação relevante para mitigar o uso irracional e a crescente resistência a esta classe de medicamentos. Desta forma, o presente estudo objetivou avaliar a utilização dos antimicrobianos mediante mensuração do consumo e avaliação de adequação do tratamento quanto à indicação, dose e duração, no período de agosto a novembro de 2019, em um hospital especializado em cardiologia. Os tratamentos iniciados de forma empírica também foram avaliados quanto à sua adequação após resultado de cultura e teste de sensibilidade a antimicrobianos, e, no caso de necessidade, à realização de ajuste. Ademais, aplicou-se a classificação da Organização Mundial de Saúde (OMS) em que os antimicrobianos são agrupados, conforme o impacto do seu uso na resistência microbiana e a importância do seu uso adequado e restrito, nas categorias Access, Watch e Reserve (AwaRe), a estes tratamentos. Foram avaliadas 1558 prescrições associadas a 405 tratamentos. As classes terapêuticas mais utilizadas foram as penicilinas combinadas, carbapenêmicos e cefalosporinas de terceira geração. A adequação na indicação foi observada em 84,2% dos casos. Dentre esses, 88,1% e 90,6% apresentavam, respectivamente, dose e duração do tratamento adequadas. Os tratamentos iniciados empiricamente foram realizados majoritariamente (58,7%) com antimicrobianos do grupo Watch, seguido do grupo Reserve (23,5%) e Access (17,8%). O ajuste de terapia foi realizado em 59% dos casos que os necessitavam (57,9%). Os resultaos sugerem que o uso de antimicrobianos deve ser aperfeiçoado, buscando minimizar o uso empírico, favorecer o uso de antimicrobianos da categoria Access e promover a adequação dos tratamentos empíricos após resultados de cultura.
- 21 February 2024
- Published by Editora Unijui in Revista Contexto & Saúde
- Vol. 24 (48) , e14385
Open AccessUso de antimicrobianos em hospital especializado em cardiologia
The management of antimicrobial use has been recognized as a relevant action to mitigate irrational use and the increasing resistance to this class of drugs. Thus, the present study aimed to evaluate the use of antimicrobials by measuring consumption and assessing the appropriateness of treatment regarding indication, dose, and duration, from August to November 2019, in a cardiology specialized hospital. Empirically initiated treatments were also evaluated for their adequacy following culture results and antimicrobial sensitivity testing, with adjustments made as necessary. Additionally, the World Health Organization (WHO) classification was applied, categorizing antimicrobials into Access, Watch, and Reserve (AWaRe) groups based on the impact of their use on microbial resistance and the importance of their appropriate and restricted use. A total of 1558 prescriptions associated with 405 treatments were evaluated. The most commonly used therapeutic classes were combined penicillins, carbapenems, and third-generation cephalosporins. Adequacy in indication was observed in 84.2% of cases. Among these, 88.1% and 90.6% exhibited appropriate dose and treatment duration, respectively. Empirically initiated treatments were predominantly conducted (58.7%) with antimicrobials from the Watch group, followed by the Reserve group (23.5%) and Access group (17.8%). Therapy adjustment was performed in 59% of cases requiring it (57.9%). The results suggest that antimicrobial use should be optimized, aiming to minimize empirical use, favor the use of antimicrobials from the Access category, and promote the adequacy of empirical treatments following culture results. O gerenciamento do uso de antimicrobianos tem sido apontado como ação relevante para mitigar o uso irracional e a crescente resistência a esta classe de medicamentos. Desta forma, o presente estudo objetivou avaliar a utilização dos antimicrobianos mediante mensuração do consumo e avaliação de adequação do tratamento quanto à indicação, dose e duração, no período de agosto a novembro de 2019, em um hospital especializado em cardiologia. Os tratamentos iniciados de forma empírica também foram avaliados quanto à sua adequação após resultado de cultura e teste de sensibilidade a antimicrobianos, e, no caso de necessidade, à realização de ajuste. Ademais, aplicou-se a classificação da Organização Mundial de Saúde (OMS) em que os antimicrobianos são agrupados, conforme o impacto do seu uso na resistência microbiana e a importância do seu uso adequado e restrito, nas categorias Access, Watch e Reserve (AwaRe), a estes tratamentos. Foram avaliadas 1558 prescrições associadas a 405 tratamentos. As classes terapêuticas mais utilizadas foram as penicilinas combinadas, carbapenêmicos e cefalosporinas de terceira geração. A adequação na indicação foi observada em 84,2% dos casos. Dentre esses, 88,1% e 90,6% apresentavam, respectivamente, dose e duração do tratamento adequadas. Os tratamentos iniciados empiricamente foram realizados majoritariamente (58,7%) com antimicrobianos do grupo Watch, seguido do grupo Reserve (23,5%) e Access (17,8%). O ajuste de terapia foi realizado em 59% dos casos que os necessitavam (57,9%). Os resultaos sugerem que o uso de antimicrobianos deve ser aperfeiçoado, buscando minimizar o uso empírico, favorecer o uso de antimicrobianos da categoria Access e promover a adequação dos tratamentos empíricos após resultados de cultura.
- Open Access
- 26 July 2023
- Published by Universidade Estadual de Maringa in Acta Scientiarum. Biological Sciences
- Vol. 45, e65725
Antibiofilm activity of bromelain from pineapple against Staphylococcus aureus
Bromelain is a set of proteolytic enzymes usually obtained from pineapple (Ananas comosus). Although bromelain has distinguished therapeutic properties, little is known about its proteolytic potential against opportunistic pathogens related to wound healing complications, such as Staphylococcus aureus. This study aimed to investigate the antibiofilm and antibacterial activity of bromelain in 43 clinical strains of S. aureus isolated from chronic wounds and blood cultures. Bromelain’s activity against S. aureus biofilm in vitro was assessed by analyzing biofilm formation in cultures grown in the presence of 1% bromelain and biofilm destruction after the addition of 1% bromelain to mature biofilms. Proteinase K and sodium metaperiodate were also added to mature biofilms in parallel to compare their activity with that of bromelain and, together with exopolysaccharide and protein production rate assays, to determine the chemical composition of the biofilm extracellular matrix of selected strains of S. aureus. Bromelain was also evaluated for its DNase activity and impact on cellular hydrophobicity and auto-aggregation. Mueller-Hinton agar dilution was used to determine bromelain minimal inhibitory concentration (MIC). Biofilm assays showed that 1% bromelain significantly inhibits S. aureus biofilm formation (p = 0.0157) by up to 4-fold and destroys its mature biofilms (p < 0.0001) by up to 6.4-fold, both compared to the control grown without bromelain. Biofilms of methicillin-resistant S. aureus strains isolated from chronic wounds were the most affected by bromelain treatment. No antibacterial activity was detected with bromelain MIC assays and the proteolytic activity of bromelain was identified as the main antibiofilm mechanism of the enzyme, though its DNase activity may also contribute. The epithelial therapeutic properties of bromelain combined with its antibiofilm activity against S. aureus make it a promising alternative to compose the therapeutic arsenal for the control of S. aureus biofilms in the context of wound care.
- 26 July 2023
- Published by Universidade Estadual de Maringa in Acta Scientiarum. Biological Sciences
- Vol. 45, e65725
Open AccessAntibiofilm activity of bromelain from pineapple against Staphylococcus aureus
Bromelain is a set of proteolytic enzymes usually obtained from pineapple (Ananas comosus). Although bromelain has distinguished therapeutic properties, little is known about its proteolytic potential against opportunistic pathogens related to wound healing complications, such as Staphylococcus aureus. This study aimed to investigate the antibiofilm and antibacterial activity of bromelain in 43 clinical strains of S. aureus isolated from chronic wounds and blood cultures. Bromelain’s activity against S. aureus biofilm in vitro was assessed by analyzing biofilm formation in cultures grown in the presence of 1% bromelain and biofilm destruction after the addition of 1% bromelain to mature biofilms. Proteinase K and sodium metaperiodate were also added to mature biofilms in parallel to compare their activity with that of bromelain and, together with exopolysaccharide and protein production rate assays, to determine the chemical composition of the biofilm extracellular matrix of selected strains of S. aureus. Bromelain was also evaluated for its DNase activity and impact on cellular hydrophobicity and auto-aggregation. Mueller-Hinton agar dilution was used to determine bromelain minimal inhibitory concentration (MIC). Biofilm assays showed that 1% bromelain significantly inhibits S. aureus biofilm formation (p = 0.0157) by up to 4-fold and destroys its mature biofilms (p < 0.0001) by up to 6.4-fold, both compared to the control grown without bromelain. Biofilms of methicillin-resistant S. aureus strains isolated from chronic wounds were the most affected by bromelain treatment. No antibacterial activity was detected with bromelain MIC assays and the proteolytic activity of bromelain was identified as the main antibiofilm mechanism of the enzyme, though its DNase activity may also contribute. The epithelial therapeutic properties of bromelain combined with its antibiofilm activity against S. aureus make it a promising alternative to compose the therapeutic arsenal for the control of S. aureus biofilms in the context of wound care.
- Open Access
Effectiveness of Epidermal Growth Factor Loaded Carboxymethylcellulose (EGF-CMC) Hydrogel in Biofilm Formation in Wounds of Diabetic Patients: A Randomized Clinical Trial
Diabetic patients frequently develop wounds, which can be colonized by bacteria, mainly Staphylococcus aureus and Pseudomonas aeruginosa, with the ability to form biofilms. This study aimed to evaluate the colonization and biofilm formation of Staphylococcus aureus and Pseudomonas aeruginosa in chronic wounds of diabetic patients treated with a bioactive dressing (EGF-CMC), which consisted of a 2% carboxymethylcellulose (CMC) hydrogel loaded with epidermal growth factor (EGF). This randomized clinical trial was conducted with 25 participants: 14 treated with EGF-CMC hydrogel and 11 treated with CMC hydrogel for 12 weeks. Participants with type 2 diabetes mellitus were selected. All had diabetic foot ulcers or chronic venous ulcers. Swab collections were performed on weeks 1, 6, and 12. The laboratory analyses included the identification of strains, microbial quantification, virulence gene investigation, and the evaluation of biofilm formation. In total, 13 S. aureus strains and 15 P. aeruginosa strains were isolated. There were no statistically significant differences regarding bacterial loads and virulence genes. However, EGF-CMC-hydrogel-treated wounds were colonized by strains with lower biofilm formation abilities. The probability of isolating biofilm-producing strains from CMC-hydrogel-treated wounds was 83% greater than the probability of isolating biofilm-producing strains from EGF-CMC-treated wounds.
Open AccessEffectiveness of Epidermal Growth Factor Loaded Carboxymethylcellulose (EGF-CMC) Hydrogel in Biofilm Formation in Wounds of Diabetic Patients: A Randomized Clinical Trial
Diabetic patients frequently develop wounds, which can be colonized by bacteria, mainly Staphylococcus aureus and Pseudomonas aeruginosa, with the ability to form biofilms. This study aimed to evaluate the colonization and biofilm formation of Staphylococcus aureus and Pseudomonas aeruginosa in chronic wounds of diabetic patients treated with a bioactive dressing (EGF-CMC), which consisted of a 2% carboxymethylcellulose (CMC) hydrogel loaded with epidermal growth factor (EGF). This randomized clinical trial was conducted with 25 participants: 14 treated with EGF-CMC hydrogel and 11 treated with CMC hydrogel for 12 weeks. Participants with type 2 diabetes mellitus were selected. All had diabetic foot ulcers or chronic venous ulcers. Swab collections were performed on weeks 1, 6, and 12. The laboratory analyses included the identification of strains, microbial quantification, virulence gene investigation, and the evaluation of biofilm formation. In total, 13 S. aureus strains and 15 P. aeruginosa strains were isolated. There were no statistically significant differences regarding bacterial loads and virulence genes. However, EGF-CMC-hydrogel-treated wounds were colonized by strains with lower biofilm formation abilities. The probability of isolating biofilm-producing strains from CMC-hydrogel-treated wounds was 83% greater than the probability of isolating biofilm-producing strains from EGF-CMC-treated wounds.
- Open Access
- 26 September 2022
- Published by Research, Society and Development in Research, Society and Development
- Vol. 11 (13)
Carbapenem resistance in non-carbapenemase-producing Pseudomonas aeruginosa strains: the role importance of OprD and AmpC
Carbapenem-resistance is a great challenge for antimicrobial therapy in Pseudomonas aeruginosa multidrug-resistant infections, as it reduces therapeutic options. This study investigated carbapenem-resistance mechanisms in six strains of non-carbapenemase-producing P. aeruginosa. Minimal inhibitory concentrations for imipenem and meropenem were determined by epsilometric test and broth microdilution. Mutations in the oprD gene were investigated by PCR, followed by sequencing. Transcriptional levels of oprD, ampC, and efflux pumps genes were analysed through RT-qPCR. Detection of efflux and AmpC activity was assessed by MIC reduction in the presence of the inhibitors: PAβN and cloxacillin, respectively. Resistant strains showed moderate levels of resistance for the evaluated carbapenems. Sequencing of oprD gene revealed similar mutation patterns in strains of the same Sequence Type -ST. A premature stop codon was detected only in the resistant strains of ST2236. Indel mutations were found in the oprD gene of ST2237 strains. Failure to detect oprD transcripts by RT-qPCR further confirms the absence of porin on ST2237 strains. ST2236 strains showed low transcriptional levels for oprD. MexXY-OprM was the only efflux system overexpressed in resistant strains. However, no efflux and AmpC activity was detected. High transcriptional levels of ampC were found in 50% of non-induced resistant strains. All imipem-induced resistant strains showed an increase in ampC expression (>102 - 103 X). It was concluded that the reduction and/or loss of OprD associated with AmpC overexpression is probably the main carbapenem-resistance mechanism in the evaluated strains.
- 26 September 2022
- Published by Research, Society and Development in Research, Society and Development
- Vol. 11 (13)
Open AccessCarbapenem resistance in non-carbapenemase-producing Pseudomonas aeruginosa strains: the role importance of OprD and AmpC
Carbapenem-resistance is a great challenge for antimicrobial therapy in Pseudomonas aeruginosa multidrug-resistant infections, as it reduces therapeutic options. This study investigated carbapenem-resistance mechanisms in six strains of non-carbapenemase-producing P. aeruginosa. Minimal inhibitory concentrations for imipenem and meropenem were determined by epsilometric test and broth microdilution. Mutations in the oprD gene were investigated by PCR, followed by sequencing. Transcriptional levels of oprD, ampC, and efflux pumps genes were analysed through RT-qPCR. Detection of efflux and AmpC activity was assessed by MIC reduction in the presence of the inhibitors: PAβN and cloxacillin, respectively. Resistant strains showed moderate levels of resistance for the evaluated carbapenems. Sequencing of oprD gene revealed similar mutation patterns in strains of the same Sequence Type -ST. A premature stop codon was detected only in the resistant strains of ST2236. Indel mutations were found in the oprD gene of ST2237 strains. Failure to detect oprD transcripts by RT-qPCR further confirms the absence of porin on ST2237 strains. ST2236 strains showed low transcriptional levels for oprD. MexXY-OprM was the only efflux system overexpressed in resistant strains. However, no efflux and AmpC activity was detected. High transcriptional levels of ampC were found in 50% of non-induced resistant strains. All imipem-induced resistant strains showed an increase in ampC expression (>102 - 103 X). It was concluded that the reduction and/or loss of OprD associated with AmpC overexpression is probably the main carbapenem-resistance mechanism in the evaluated strains.
- Open Access
- 7 August 2020
- Published by Research, Society and Development in Research, Society and Development
- Vol. 9 (9) , e83996975
Avaliação da eficácia de biocidas na remoção de biofilmes produzidos por Pseudomonas aeruginosa multidroga resistentes
Pseudomonas aeruginosa é um dos patógenos mais frequentes em infecções acometendo pacientes queimados, tendo como importante determinante de patogenicidade sua capacidade de formar biofilmes. O presente trabalho tem por objetivo avaliar a eficácia das soluções biocidas: clorexidina 4%, hipoclorito de sódio 1%, peróxido de hidrogênio 5% e álcool 70% na remoção de biofilmes de P. aeruginosa multidroga resistentes. Trata-se de um estudo descritivo de abordagem quantitativa. Foram avaliados biofilmes de nove cepas de P. aeruginosa, de diferentes tipos clonais, sendo oito resistentes a carbapenêmicos e uma sensível, coletadas de pacientes queimados e mesas de balneoterapia. As cepas estudas foram cultivadas juntamente com cupons de aço inoxidável, e incubadas por 24 h. Posteriormente, os cupons foram tratados com e sem biocidas, nos tempos de contato de 15, 5 e 0 minutos. A remoção do biofilme foi avaliada através da contagem de células viáveis obtidas dos cupons com e sem tratamento. A concentração mínima inibitória ao imipenem e meropenem foi determinada para cepas avaliadas através do método epsilométrico. Foi observado formação de biofilme em todos os cupons não tratados com biocidas. Entretanto, não houve contagem de células viáveis após contato do biofilme com todas soluções biocidas, nos tempos estudados. A concentração mínima inibitória aos carbapenêmicos variou entre 16 a ≥ 32µg/mL. Concluiu-se que todas a soluções desinfetantes avaliadas, foram eficazes na remoção de biofilmes produzidos pelas cepas de P. aeruginosa estudadas.
- 7 August 2020
- Published by Research, Society and Development in Research, Society and Development
- Vol. 9 (9) , e83996975
Open AccessAvaliação da eficácia de biocidas na remoção de biofilmes produzidos por Pseudomonas aeruginosa multidroga resistentes
Pseudomonas aeruginosa é um dos patógenos mais frequentes em infecções acometendo pacientes queimados, tendo como importante determinante de patogenicidade sua capacidade de formar biofilmes. O presente trabalho tem por objetivo avaliar a eficácia das soluções biocidas: clorexidina 4%, hipoclorito de sódio 1%, peróxido de hidrogênio 5% e álcool 70% na remoção de biofilmes de P. aeruginosa multidroga resistentes. Trata-se de um estudo descritivo de abordagem quantitativa. Foram avaliados biofilmes de nove cepas de P. aeruginosa, de diferentes tipos clonais, sendo oito resistentes a carbapenêmicos e uma sensível, coletadas de pacientes queimados e mesas de balneoterapia. As cepas estudas foram cultivadas juntamente com cupons de aço inoxidável, e incubadas por 24 h. Posteriormente, os cupons foram tratados com e sem biocidas, nos tempos de contato de 15, 5 e 0 minutos. A remoção do biofilme foi avaliada através da contagem de células viáveis obtidas dos cupons com e sem tratamento. A concentração mínima inibitória ao imipenem e meropenem foi determinada para cepas avaliadas através do método epsilométrico. Foi observado formação de biofilme em todos os cupons não tratados com biocidas. Entretanto, não houve contagem de células viáveis após contato do biofilme com todas soluções biocidas, nos tempos estudados. A concentração mínima inibitória aos carbapenêmicos variou entre 16 a ≥ 32µg/mL. Concluiu-se que todas a soluções desinfetantes avaliadas, foram eficazes na remoção de biofilmes produzidos pelas cepas de P. aeruginosa estudadas.